Central serous chorioretinopathy: a pathogenetic model Clinical Ophthalmology Dove
... vasoconstriction. Ketoconazole exerts its effects by inhibiting some steps in the steroid synthesis resulting in decreased levels of cortisol, androgen, and aldosterone and in elevated progesterone. These effects seem to be present at the minimum dosage of 400 mg/day. An additional action of ketoco ...
... vasoconstriction. Ketoconazole exerts its effects by inhibiting some steps in the steroid synthesis resulting in decreased levels of cortisol, androgen, and aldosterone and in elevated progesterone. These effects seem to be present at the minimum dosage of 400 mg/day. An additional action of ketoco ...
inside - Australian Doctor
... Nervous system involvement is again less common but, as with cardiac involvement, may cause significant morbidity and mortality. Up to 5% of patients have neurological involvement and, ...
... Nervous system involvement is again less common but, as with cardiac involvement, may cause significant morbidity and mortality. Up to 5% of patients have neurological involvement and, ...
5
... large variation in LBP diagnoses, and a multitude of poorly studied interventions.4 It has been assumed that randomized controlled trials (RCTs) could provide answers to questions such as ‘which intervention is most effective for which patient’, but after the publication of more than 1,000 RCTs focu ...
... large variation in LBP diagnoses, and a multitude of poorly studied interventions.4 It has been assumed that randomized controlled trials (RCTs) could provide answers to questions such as ‘which intervention is most effective for which patient’, but after the publication of more than 1,000 RCTs focu ...
Therapy of myositis: biological and physical
... extension revealed that only quadriceps strength improvement was sustained whereas all other variables returned to the baseline values, indicating that continuing exercise is necessary to maintain and improve function and health. Eight patients with JDM in remission but with muscle impairment, ages ...
... extension revealed that only quadriceps strength improvement was sustained whereas all other variables returned to the baseline values, indicating that continuing exercise is necessary to maintain and improve function and health. Eight patients with JDM in remission but with muscle impairment, ages ...
Clinical Bulletin - National Multiple Sclerosis Society
... slowly titrated up to minimize sedation and to identify the lowest effective dose. Patients and family members become adept at making minor dose adjustments to control changes in tone that occur secondary to infection, stress, and other causes previously discussed. Patients may experience fatigue or ...
... slowly titrated up to minimize sedation and to identify the lowest effective dose. Patients and family members become adept at making minor dose adjustments to control changes in tone that occur secondary to infection, stress, and other causes previously discussed. Patients may experience fatigue or ...
Jelly Fish Anaphylaxis
... 7. C Loten, B Stokes, D Worsley, J Seymour, S Jiang, G Isbister. A randomised controlled trial of hot water (45°C) immersion versus ice packs for pain relief in bluebottle stings. MJA April 2006. 184(7):329-333. 8. Russo, A.J.; Calton, G.J.; Burnett, J.W. The relationship of the possible allergic re ...
... 7. C Loten, B Stokes, D Worsley, J Seymour, S Jiang, G Isbister. A randomised controlled trial of hot water (45°C) immersion versus ice packs for pain relief in bluebottle stings. MJA April 2006. 184(7):329-333. 8. Russo, A.J.; Calton, G.J.; Burnett, J.W. The relationship of the possible allergic re ...
Lower urinary tract symptoms and benign prostatic hyperplasia
... Given that different classes of drugs target different LUTS, some patients respond better to a combination of drugs from different classes rather than using separate drugs in isolation. In general, the authors tend to prescribe tamsulosin 400 µg/day as a first-line medication for men with LUTS. This ...
... Given that different classes of drugs target different LUTS, some patients respond better to a combination of drugs from different classes rather than using separate drugs in isolation. In general, the authors tend to prescribe tamsulosin 400 µg/day as a first-line medication for men with LUTS. This ...
ZONALON® (doxepin hydrochloride) CREAM, 5% FOR TOPICAL
... may vary and is dependent upon the particular MAO inhibitor being used, the length of time it has been administered, and the dosage involved. Cimetidine: Serious anticholinergic symptoms (i.e., severe dry mouth, urinary retention and blurred vision) have been associated with elevations in the serum ...
... may vary and is dependent upon the particular MAO inhibitor being used, the length of time it has been administered, and the dosage involved. Cimetidine: Serious anticholinergic symptoms (i.e., severe dry mouth, urinary retention and blurred vision) have been associated with elevations in the serum ...
Veterinary Homeopathy
... Can homeopathy be combined with other types of veterinary medicine? Homeopathy is useful as an adjunct therapy to manage post-operative pain and to speed healing after injuries. However, as a complete and well-developed system of medicine, homeopathy is effective as the sole form of treatment for m ...
... Can homeopathy be combined with other types of veterinary medicine? Homeopathy is useful as an adjunct therapy to manage post-operative pain and to speed healing after injuries. However, as a complete and well-developed system of medicine, homeopathy is effective as the sole form of treatment for m ...
InterStim Therapy for Urinary Incontinence
... patients who have failed or are not candidates for more conservative treatments. Contraindications: Diathermy. Patients who have not demonstrated an appropriate response to test stimulation or are unable to operate the neurostimulator. Precautions/Adverse Events: Safety and effectiveness have not be ...
... patients who have failed or are not candidates for more conservative treatments. Contraindications: Diathermy. Patients who have not demonstrated an appropriate response to test stimulation or are unable to operate the neurostimulator. Precautions/Adverse Events: Safety and effectiveness have not be ...
Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in
... adjustment for potential confounders, drivers who consumed caffeinated substances for this purpose had a 63% reduced likelihood of crashing (odds ratio 0.37, 95% confidence interval 0.27 to 0.50) compared with drivers who did not take caffeinated substances. Bias, confounding, and other reasons for ...
... adjustment for potential confounders, drivers who consumed caffeinated substances for this purpose had a 63% reduced likelihood of crashing (odds ratio 0.37, 95% confidence interval 0.27 to 0.50) compared with drivers who did not take caffeinated substances. Bias, confounding, and other reasons for ...
skin - The Dermatologist
... 71% improvement in Psoriasis Area and Severity Index [PASI] at DEALING WITH SEVERE CASES Case studies from my practice show some common scenarios 24 weeks versus 62% improvement with 25 mg.) Similar results occur with other biologic agents such as inflixin treating severe psoriasis. The first involv ...
... 71% improvement in Psoriasis Area and Severity Index [PASI] at DEALING WITH SEVERE CASES Case studies from my practice show some common scenarios 24 weeks versus 62% improvement with 25 mg.) Similar results occur with other biologic agents such as inflixin treating severe psoriasis. The first involv ...
Shortage memo phenotolamine and phenoxybenzamine
... chromaffin cells of the adrenal medulla. Although it may be malignant, symptoms usually result from the excess secretion of catecholamines 2 and include hypertension, headaches, palpitations, and excessive sweating. If the effects of the release of catecholamines are not controlled, a life-threateni ...
... chromaffin cells of the adrenal medulla. Although it may be malignant, symptoms usually result from the excess secretion of catecholamines 2 and include hypertension, headaches, palpitations, and excessive sweating. If the effects of the release of catecholamines are not controlled, a life-threateni ...
October 2008
... Refractory symptoms are considered symptoms for which all possible treatments have failed. A patient experiencing refractory symptoms must be differentiated from a patient who has symptoms that are difficult to treat. Refractory symptoms are symptoms that the palliative care physician and team deter ...
... Refractory symptoms are considered symptoms for which all possible treatments have failed. A patient experiencing refractory symptoms must be differentiated from a patient who has symptoms that are difficult to treat. Refractory symptoms are symptoms that the palliative care physician and team deter ...
Mark Berry
... 2006 – by joking that he “dreams about this place”. But really, said Gibson, the idea is to stop people dreaming…”because the thing about dreams is, then you wake up!”. Gibson seemed to feel the same sense of hope and excitement that many of the people I spoke to at the conference expressed: “Things ...
... 2006 – by joking that he “dreams about this place”. But really, said Gibson, the idea is to stop people dreaming…”because the thing about dreams is, then you wake up!”. Gibson seemed to feel the same sense of hope and excitement that many of the people I spoke to at the conference expressed: “Things ...
RISPERDAL CONSTA - Dosing - Dosage and Administration
... for the maintenance treatment of Bipolar I Disorder is 25 mg intramuscular injection every 2 weeks. Some patients not responding to 25 mg may benefit from a higher dose of 37.5 mg or 50 mg every 2 weeks.1 A lower initial dose of RISPERDAL CONSTA 12.5 mg may be appropriate when clinical factors warra ...
... for the maintenance treatment of Bipolar I Disorder is 25 mg intramuscular injection every 2 weeks. Some patients not responding to 25 mg may benefit from a higher dose of 37.5 mg or 50 mg every 2 weeks.1 A lower initial dose of RISPERDAL CONSTA 12.5 mg may be appropriate when clinical factors warra ...
Vaccination of Patients with Small-Cell Lung Cancer with Synthetic
... Six patients were enrolled at the 30-g dose level, and five patients were enrolled at the 10- and 3-g dose levels. Baseline patient characteristics are specified in Table 1. Three patients at the 30-g dose level and one patient at the 3-g dose level received five of six planned injections, and t ...
... Six patients were enrolled at the 30-g dose level, and five patients were enrolled at the 10- and 3-g dose levels. Baseline patient characteristics are specified in Table 1. Three patients at the 30-g dose level and one patient at the 3-g dose level received five of six planned injections, and t ...
A Decade of Innovation in Rare Diseases
... exploring use of TKIs in combination with other cancer-fighting agents.31 As knowledge of the underlying disease pathway has grown, researchers have also identified a new mechanism of action for combatting CML. In 2012, the FDA approved a new, first-inclass treatment called omacetaxine mepusuccinate ...
... exploring use of TKIs in combination with other cancer-fighting agents.31 As knowledge of the underlying disease pathway has grown, researchers have also identified a new mechanism of action for combatting CML. In 2012, the FDA approved a new, first-inclass treatment called omacetaxine mepusuccinate ...
Jemds.com
... Journal of Evolution of Medical and Dental Sciences/ eISSN- 2278-4802, pISSN- 2278-4748/ Vol. 4/ Issue 99/ Dec. 10, 2015 ...
... Journal of Evolution of Medical and Dental Sciences/ eISSN- 2278-4802, pISSN- 2278-4748/ Vol. 4/ Issue 99/ Dec. 10, 2015 ...
summary - USDOCTOR.com
... engaging in illegal conduct that gave certain contractors “most favored nation” status . These alleged illegal acts were systematic and pervasive (See Exhibit 2). In 1995, Blue Cross/Blue Shield of Michigan paid a total of $51.6 million to settle charges that it falsified audit reports and used Medi ...
... engaging in illegal conduct that gave certain contractors “most favored nation” status . These alleged illegal acts were systematic and pervasive (See Exhibit 2). In 1995, Blue Cross/Blue Shield of Michigan paid a total of $51.6 million to settle charges that it falsified audit reports and used Medi ...
Myositis 101 - The Myositis Association
... treatment in a month or two, showing improvement in blood tests and in physical strength. More difficult cases may have flares that last a year or longer, and some cases respond immediately, with no reoccurrence. IBM patients have a slow-progressing disease, with no effective treatment. Patients dia ...
... treatment in a month or two, showing improvement in blood tests and in physical strength. More difficult cases may have flares that last a year or longer, and some cases respond immediately, with no reoccurrence. IBM patients have a slow-progressing disease, with no effective treatment. Patients dia ...
myositis 101 - The Myositis Association
... treatment in a month or two, showing improvement in blood tests and in physical strength. More difficult cases may have flares that last a year or longer, and some cases respond immediately, with no reoccurrence. IBM patients have a slow-progressing disease, with no effective treatment. Patients dia ...
... treatment in a month or two, showing improvement in blood tests and in physical strength. More difficult cases may have flares that last a year or longer, and some cases respond immediately, with no reoccurrence. IBM patients have a slow-progressing disease, with no effective treatment. Patients dia ...
the 2014 HIV/STD Update
... • Modest reduction in EFV levels does not appear to reduce EFV activity • EFV-based ART (600 mg) with RIFbased TB therapy is regimen of choice ...
... • Modest reduction in EFV levels does not appear to reduce EFV activity • EFV-based ART (600 mg) with RIFbased TB therapy is regimen of choice ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.